Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis
- PMID: 32436124
- DOI: 10.1007/s10620-020-06347-7
Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis
Abstract
Background: Standard of care treatment for AIH includes prednisone monotherapy or dual therapy prednisone-azathioprine. However, many hepatologists alternatively use azathioprine monotherapy to avoid side effects of long-term corticosteroids.
Aims: To determine whether azathioprine monotherapy is comparable to dual prednisone-azathioprine for maintenance of remission in AIH.
Methods: A retrospective chart review of 260 individuals with AIH from a single institution was performed; 45 individuals were included. Exclusion criteria included concomitant PBC or PSC, use of alternative treatment regimen, and/or failure to reach remission. Treatment regimen received was guided by clinician standard of practice, not patients' clinical factors. Initial remission was defined as normalization of serum ALT for at least two consecutive blood draws. Data were analyzed for 5 years post-remission, recording outcome and dose of prednisone and/or azathioprine.
Results: 83% of individuals were female, and average age was 65 years. Median dose of prednisone and azathioprine for the dual-therapy group was 5 mg and 100 mg, respectively, while median azathioprine dose for the monotherapy group was 75 mg. Considering overall outcome, 93% of all patients maintained remission. 80% of the dual-therapy group, and 95% of the azathioprine monotherapy group maintained remission. Using Chi-square analysis to compare the maintenance of remission between dual therapy and azathioprine monotherapy, a p value of 0.28 was calculated.
Conclusions: AASLD guidelines recommend dual prednisone-azathioprine as standard of care for maintenance of remission in AIH. Our results suggest that azathioprine monotherapy is equivalent to prednisone-azathioprine. Azathioprine monotherapy offers a significant advantage in mitigating risks of long-term corticosteroid therapy.
Keywords: Autoimmune hepatitis; Azathioprine; Chronic corticosteroid use; Maintenance of remission; Standard of care.
Similar articles
-
Real-world evidence for factors associated with maintenance treatment practices among US adults with autoimmune hepatitis.Hepatology. 2025 Feb 1;81(2):423-435. doi: 10.1097/HEP.0000000000000961. Epub 2024 Jun 12. Hepatology. 2025. PMID: 38865589
-
Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):353-6. doi: 10.1097/01.mpg.0000232331.93052.dd. J Pediatr Gastroenterol Nutr. 2006. PMID: 16954959
-
Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.J Pediatr. 2013 Nov;163(5):1347-53.e1. doi: 10.1016/j.jpeds.2013.05.042. Epub 2013 Jun 28. J Pediatr. 2013. PMID: 23810723 Clinical Trial.
-
Drug therapy in the management of type 1 autoimmune hepatitis.Drugs. 1999 Jan;57(1):49-68. doi: 10.2165/00003495-199957010-00005. Drugs. 1999. PMID: 9951951 Review.
-
Budesonide for the treatment of autoimmune hepatitis.Ann Pharmacother. 2011 Sep;45(9):1144-50. doi: 10.1345/aph.1Q244. Epub 2011 Aug 30. Ann Pharmacother. 2011. PMID: 21878659 Review.
Cited by
-
Real-world evidence for factors associated with maintenance treatment practices among US adults with autoimmune hepatitis.Hepatology. 2025 Feb 1;81(2):423-435. doi: 10.1097/HEP.0000000000000961. Epub 2024 Jun 12. Hepatology. 2025. PMID: 38865589
-
Purification and characterization of a novel immunoregulatory peptide from Sipunculus nudus L. protein.Food Sci Nutr. 2023 Sep 26;11(12):7779-7790. doi: 10.1002/fsn3.3695. eCollection 2023 Dec. Food Sci Nutr. 2023. PMID: 38107114 Free PMC article.
-
CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.Front Immunol. 2021 Mar 19;12:578548. doi: 10.3389/fimmu.2021.578548. eCollection 2021. Front Immunol. 2021. PMID: 33815355 Free PMC article.
References
-
- Czaja A. Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver. 2016;10:177. - DOI
-
- Johnson P, McFarlane I, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med. 1995;333:958–963. - DOI
-
- Kanzler S, Löhr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol. 2001;39:339–344. - DOI
-
- zum Büschenfelde KHM, Lohse AW. Autoimmune hepatitis. N Engl J Med. 1995;333:1004–1005. - DOI
-
- Czaja A. Safety issues in the management of autoimmune hepatitis. Expert Opin Drug Saf. 2008;7:319–333. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical